Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020-17 May 2021): a population-level observational study.
BMJ Open
; 12(3): e055278, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1723800
ABSTRACT
OBJECTIVE:
To determine characteristics associated with COVID-19 vaccine coverage among individuals aged 50 years and above in England since the beginning of the programme.DESIGN:
Observational cross-sectional study assessed by logistic regression and mean prevalence margins.SETTING:
COVID-19 vaccinations delivered in England from 8 December 2020 to 17 May 2021.PARTICIPANTS:
30 624 257/61 967 781 (49.4%) and 17 360 045/61 967 781 (28.1%) individuals in England were recorded as vaccinated in the National Immunisation Management System with a first dose and a second dose of a COVID-19 vaccine, respectively.INTERVENTIONS:
Vaccination status with COVID-19 vaccinations. MAIN OUTCOMEMEASURES:
Proportion, adjusted ORs and mean prevalence margins for individuals not vaccinated with dose 1 among those aged 50-69 years and dose 1 and 2 among those aged 70 years and above.RESULTS:
Of individuals aged 50 years and above, black/African/Caribbean ethnic group was the least likely of all ethnic groups to be vaccinated with dose 1 of the COVID-19 vaccine. However, of those aged 70 years and above, the odds of not having dose 2 was 5.53 (95% CI 5.42 to 5.63) and 5.36 (95% CI 5.29 to 5.43) greater among Pakistani and black/African/Caribbean compared with white British ethnicity, respectively. The odds of not receiving dose 2 was 1.18 (95% CI 1.16 to 1.20) higher among individuals who lived in a care home compared with those who did not. This was the opposite to that observed for dose 1, where the odds of being unvaccinated was significantly higher among those not living in a care home (0.89 (95% CI 0.87 to 0.91)).CONCLUSIONS:
We found that there are characteristics associated with low COVID-19 vaccine coverage. Inequalities, such as ethnicity are a major contributor to suboptimal coverage and tailored interventions are required to improve coverage and protect the population from SARS-CoV-2.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Vacunas contra la COVID-19
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
Tópicos:
Vacunas
Límite:
Adulto
/
Anciano
/
Humanos
/
Middle aged
País/Región como asunto:
Europa
Idioma:
Inglés
Revista:
BMJ Open
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Bmjopen-2021-055278
Similares
MEDLINE
...
LILACS
LIS